149(top 1%)
papers
6.4K(top 1%)
citations
37(top 1%)
h-index
79(top 1%)
g-index
152
all documents
6.6K
doc citations
1.2K
citing journals

Top Articles

#TitleJournalYearCitations
1Prevention of thalidomide- and lenalidomide-associated thrombosis in myelomaLeukemia2008787
2Graft-versus-myeloma effect: proof of principleBlood1996525
3Superiority of Tandem Autologous Transplantation Over Standard Therapy for Previously Untreated Multiple MyelomaBlood1997520
4Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patientsBlood1995430
5Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalitiesBlood1995361
6Optimizing the Correlation between Results of Testing In Vitro and Therapeutic Outcome In Vivo for Fluconazole by Testing Critical Isolates in a Murine Model of Invasive CandidiasisAntimicrobial Agents and Chemotherapy1998168
7Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell supportBlood1992164
8High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplantsBlood1994164
9Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myelomaBritish Journal of Haematology1996148
10Autotransplants in multiple myeloma: what have we learned?Blood1996146
11Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma.Journal of Clinical Oncology1998145
12Graft-versus-myeloma effect: proof of principleBlood1996139
13Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myelomaBlood1997123
14Collection, Tumor Contamination, and Engraftment Kinetics of Highly Purified Hematopoietic Progenitor Cells to Support High Dose Therapy in Multiple MyelomaBlood1998108
15Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry dataCancer2001105
16Strategies for Avoiding Burnout in Hospice and Palliative Medicine: Peer Advice for Physicians on Achieving Longevity and FulfillmentJournal of Palliative Medicine2009104
17Racial differences in the outcome of patients with colorectal carcinomaCancer200399
18Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patientsBlood199596
19Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphomaAmerican Journal of Hematology200385
20Feasibility and cost-effectiveness of outpatient autotransplants in multiple myelomaBone Marrow Transplantation199783
21Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalitiesBlood199583
22Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancerAnnals of Thoracic Surgery200077
23Nutritional Evaluation and Supplementation of Elderly Subjects Participating in a "Meals on Wheels" ProgramJournal of Parenteral and Enteral Nutrition198574
24Sarcoidosis-like syndrome and lymphadenopathy due to checkpoint inhibitorsJournal of Oncology Pharmacy Practice201772
25Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells [see comments]Blood199671
26Veterans with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) have a Markedly Increased Rate of Second Malignancy, which is the Most Common Cause of DeathLeukemia and Lymphoma200466
27Thrombin receptor expression is upregulated in prostate cancerProstate200666
28Stage-Specific Characterization of the Vascular Endothelial Growth Factor Axis in Prostate Cancer: Expression of Lymphangiogenic Markers Is Associated with Advanced-Stage DiseaseClinical Cancer Research200564
29Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell supportBlood199259
30Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free mediumLeukemia Research200458
31Relapse of multiple myeloma after autologous transplantation: survival after salvage therapyBone Marrow Transplantation199558
32Bone marrow transplantation in multiple myelomaBone Marrow Transplantation199154
33Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage diseaseClinical Cancer Research200554
34Autotransplants in multiple myeloma: what have we learned?Blood199653
35Role of EZH2 histone methyltrasferase in melanoma progression and metastasisCancer Biology and Therapy201651
36CYTOGENETICS AND MOLECULAR GENETICS IN MULTIPLE MYELOMAHematology/Oncology Clinics of North America199750
37BIOLOGY AND THERAPY OF IMMUNOGLOBULIN DEPOSITION DISEASESHematology/Oncology Clinics of North America199748
38Severe Hemorrhagic Complication Due to Acquired Factor V Inhibitor After Single Exposure to Bovine Thrombin ProductJournal of Cardiac Surgery201042
39Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activityAnticancer Research199637
40Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattackCancer Biology and Therapy201735
41Case report of sideroblastic anemia caused by ingestion of coinsAmerican Journal of Hematology200133
42Autotransplants in multiple myeloma: what have we learned?Blood199631
43Bilateral iris tumors in an immunosuppressed childSurvey of Ophthalmology199130
44Evaluation of Vitamin D Deficiency in Breast Cancer Patients on BisphosphonatesOncologist200830
45Role of colony-stimulating factor in myelopoiesis in murine long-term bone marrow culturesBlood198729
46Targeting nano drug delivery to cancer cells using tunable, multi‐layer, silver‐decorated gold nanorodsJournal of Applied Toxicology201729
47Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell supportBlood199229
48Calreticulin associates with stress proteins: Implications for chaperone function during heat stressBlood199828
49Autologous Bone Marrow Transplantation for Multiple MyelomaHematology/Oncology Clinics of North America199227
50High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myelomaBlood199027